The regulatory role of semaphorin 3E in allergic asthma.


Journal

The international journal of biochemistry & cell biology
ISSN: 1878-5875
Titre abrégé: Int J Biochem Cell Biol
Pays: Netherlands
ID NLM: 9508482

Informations de publication

Date de publication:
01 2019
Historique:
received: 04 07 2018
revised: 06 11 2018
accepted: 12 11 2018
pubmed: 18 11 2018
medline: 19 7 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Semaphorins were originally discovered as essential mediators involved in regulation of axonal growth during development of the nervous system. Ubiquitously expressed on various organs, they control several cellular functions by regulating essential signaling pathways. Among them, semaphorin3E binds plexinD1 as the primary receptor and mediates regulatory effects on cell migration, proliferation, and angiogenesis considered major physiological and pathological features in health and disease. Recent in vitro and in vivo experimental evidence demonstrate a key regulator role of semaphorin3E on airway inflammation, hyperresponsivenss and remodeling in allergic asthma. Herein, we aim to provide a broad overview of the biology of semaphorin family and review the recently discovered regulatory role of semaphorin3E in modulating immune cells and structural cells function in the airways. These findings support the concept of semaphorin3E/plexinD1 axis as a therapeutic target in allergic asthma.

Identifiants

pubmed: 30447428
pii: S1357-2725(18)30242-5
doi: 10.1016/j.biocel.2018.11.006
pii:
doi:

Substances chimiques

Cell Adhesion Molecules, Neuronal 0
Intracellular Signaling Peptides and Proteins 0
Membrane Glycoproteins 0
PLXND1 protein, human 0
SEMA3E protein, human 0
Semaphorins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-73

Subventions

Organisme : CIHR
ID : MOP # 115115
Pays : Canada

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Hesam Movassagh (H)

Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Latifa Koussih (L)

Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Lianyu Shan (L)

Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Abdelilah S Gounni (AS)

Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: abdel.gounni@umanitoba.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH